Inspire Advisors, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Inspire Advisors, LLC

  • $721 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023
SELL
$146.04 - $225.78 $249,582 - $385,858
-1,709 Reduced 51.98%
1,579 $230,000
Q2 2023

Jul 31, 2023
BUY
$203.88 - $312.0 $68,503 - $104,832
336 Added 11.38%
3,288 $759,000
Q1 2023

Apr 24, 2023
BUY
$231.06 - $307.08 $682,089 - $906,500
2,952 New
2,952 $715,000

Others Institutions Holding MDGL

# of Institutions
337
Shares Held
22.3M
Call Options Held
987K
Put Options Held
960K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.77B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Inspire Advisors, LLC Portfolio

Follow Inspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email